Clinical Trials in Nashville

Showing 4461-4480 of 20,298 trials

A Phase 2 Study of YA-101 in Patients With Multiple System Atrophy

NCT06848231

This is a Phase 2, double-blind, placebo-controlled, multi-center, Phase II, dose escalation study to evaluate the safety, tolerability, pharmacokinetics and efficacy of Ya-101 in subjects with multiple system atrophy.

Multiple System Atrophy

Yoda Therapeutics Inc.75 participantsStarted Mar 2025

Los Angeles, California, United States • Boston, Massachusetts, United States • Rochester, Minnesota, United States +6 more locations

Active Not RecruitingPhase 3< 1 mile

A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC)

NCT06472076

The goal of this clinical trial is to evaluate the safety and tolerability profile of dostarlimab in combination with belrestotug when compared with pembrolizumab and placebo in participants with previously untreated, unresectable, locally advanced or metastatic PD-L1 high NSCLC.

Lung Cancer, Non-Small Cell

GlaxoSmithKline88 participantsStarted Jun 2024

Ocala, Florida, United States • Honolulu, Hawaii, United States • Lexington, Kentucky, United States +131 more locations

A Phase 2 Study of YA-101 in Patients With Multiple System Atrophy

A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC)

Find Trials by Condition in Nashville

Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma

OCS DCD Heart + CAP Continued Follow-Up

First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer

Evaluation of Rifaximin SSD for Delaying Encephalopathy Decompensation in Patients With Cirrhosis

A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age

Retrospective Study of Suture Tape for Soft Tissue Reconstruction in Patients Suffering From Lateral Ankle Instability

A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed AML Ineligible for Intensive Therapy

Abatacept in Immune Checkpoint Inhibitor Myocarditis

A Safety/Tolerability and PK Study With Azstarys® in Children With ADHD

A Study of Efficacy and Safety of Pembrolizumab Plus Enfortumab Vedotin (EV) +/- Investigational Agents in First-Line Metastatic Urothelial Carcinoma (mUC) (MK-3475-04B/KEYMAKER-U04)

A Study to Evaluate the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting

A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma

A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab

FebriDx® Method Comparison Study Protocol

Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

LiveSMART Trial to Prevent Falls in Patients With Cirrhosis

A First-in-Human Dose Escalation and Expansion Study to Evaluate Intratumoral Administration of SAR441000 as Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

Phase 1 Trial in Patients With Human Papillomavirus (HPV)-Associated Cancer